The binding of Apelin to APJ and GLP-1R further underscores its versatility, as these receptors contribute to cardioprotection, glucose homeostasis, and inflammatory regulation, key factors in the systemic management of CAD. This evidence concerns the gene GLP1R and coronary artery disorder.